Hanall Biopharma Co (XKRX:009420) Change In Other Working Capital : ₩20,307 Mil (TTM As of Dec. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Hanall Biopharma Co Change In Other Working Capital?

Hanall Biopharma Co's Change In Other Working Capital for the quarter that ended in Dec. 2023 was ₩12,849 Mil. It means Hanall Biopharma Co's Other Working Capital increased by ₩12,849 Mil from Sep. 2023 to Dec. 2023 .

Hanall Biopharma Co's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was ₩20,307 Mil. It means Hanall Biopharma Co's Other Working Capital increased by ₩20,307 Mil from Dec. 2022 to Dec. 2023 .

Hanall Biopharma Co Change In Other Working Capital Historical Data

The historical data trend for Hanall Biopharma Co's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanall Biopharma Co Change In Other Working Capital Chart

Hanall Biopharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Other Working Capital

Get a 7-Day Free Trial

-3,365.03

-12,230.92

-7,816.63

23,134.71

20,306.83

Hanall Biopharma Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Other Working Capital	Get a 7-Day Free Trial															6,672.73	-2,525.47	-13,135.91	23,119.44	12,848.78

Hanall Biopharma Co Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩20,307 Mil.

Hanall Biopharma Co Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Hanall Biopharma Co's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Hanall Biopharma Co (XKRX:009420) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanall Biopharma Co Ltd (XKRX:009420) » Definitions » Change In Other Working Capital

Traded in Other Exchanges

N/A

Address

12 Bongeunsa-ro 114-gil, Daewoong Building, 3rd Floor, Gangnam-gu, Seoul, KOR

Website

http://www.hanall.co.kr

Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Hanall Biopharma Co (XKRX:009420) Headlines

No Headlines